Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05165927 · ClinicalTrials.gov registry record · NA
Comparison of Methods in Post Operative Hip Arthroscopy Rehabilitation
A NA study of Hip Injuries, sponsored by University of Colorado, Denver.
- Recruiting
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT05165927: Recruiting NA study of Hip Injuries, sponsored by University of Colorado, Denver.
NCT05165927 is a NA study of Hip Injuries that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 120 participants, below the 2,104-participant average among 7 other Hip Injuries trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05165927, a NA study of Hip Injuries, is actively recruiting participants, sponsored by University of Colorado, Denver.
- RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators plan to investigate the efficacy of blood flow restriction (BFR) therapy in post operative rehabilitation following hip arthroscopy. BFR has shown to be great at helping the recovery process. SAGA is a well-known smart training technology company, and the investigators aim to partner with SAGA to use the BFR cuffs as the intervention method. The BFR cuff will be added to the current SOC for hip scope PT for the intervention group.
Primary Outcome
1\. Strength of hip extensors via handheld dynamometry (HHD) and reported as a measure of limb symmetry index (LSI) comparing operative limb to non-operative limb. By 3 months post operatively, patients should be approaching 70% LSI in order to safely initiate impact activities such as jogging. Prior to discharge from therapy, patients should achieve at least 90% LSI per standard protocol.
Conditions Studied
Interventions
- DEVICE BFR
Study Locations (1)
Colorado
- UCHealth Steadman Hawkins Clinic Denver - Englewood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2022-04-29 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
What NCT05165927 shows while recruiting
NCT05165927 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 2,104-participant average among 7 other Hip Injuries trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Hip Injuries appearing as the primary indexed condition, and to 1 intervention - of which BFR is the first listed.
NCT05165927 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT05165927 about?
NCT05165927 is a clinical study titled "Comparison of Methods in Post Operative Hip Arthroscopy Rehabilitation". The investigators plan to investigate the efficacy of blood flow restriction (BFR) therapy in post operative rehabilitation following hip arthroscopy. BFR has shown to be great at helping the recovery process. SAGA is a well-known smart training technology company, and the investigators aim to partn...
What is the current status of trial NCT05165927?
This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2022-04-29. Estimated completion is 2025-12-31.
What conditions does trial NCT05165927 study?
This clinical trial studies the following conditions: Hip Injuries.
What interventions are being tested in trial NCT05165927?
The interventions under investigation include: BFR (DEVICE).
Who is sponsoring clinical trial NCT05165927?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05165927 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hip Injuries
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Muscle O2 Saturation and Hemoglobin Levels During Rehabilitation From Arthroscopic Surgery
RECRUITING · NA
-
Positioning for Hip Arthroscopic Surgery to Reduce Postoperative Numbness
RECRUITING · NA
-
Developing a Decision Instrument to Guide Abdominal-pelvic CT Imaging of Blunt Trauma Patients
RECRUITING
-
SportsPro: Post-Market Clinical Follow Up Study
RECRUITING
-
MDR - PMCF Study for Taperloc Complete Stems
RECRUITING
-
JuggerKnot With Broadband PMCF Study
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI